Ray L. Watts

11.9k citations

84 papers · 6.0k indexed · 2 hit papers · h-index 42

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments 54
- Neurological disorders and treatments 40
- Transcranial Magnetic Stimulation Studies 12
- Botulinum Toxin and Related Neurological Disorders 8
- Neurological diseases and metabolism 7
Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases 9
- Neuroscience and Neural Engineering 7
- Neuroscience and Neuropharmacology Research 5
Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 54
- Neurological disorders and treatments 40
- Transcranial Magnetic Stimulation Studies 12
- Botulinum Toxin and Related Neurological Disorders 8
- Neurological diseases and metabolism 7
Cognitive Neuroscience top 2%
Clinical Biochemistry top 2%

Co-authors: Jorge L. Juncos David J. Brooks Christopher G. Goetz S Fahn J. William Langston Håkan Widner Thomas B. Freeman William C. Koller
Cited by: Neurology Cellular and Molecular Neuroscience
Partner nations: United States Canada United Kingdom

In The Last Decade

Ray L. Watts

84 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
1992 Core assessment program for intracerebral transplantations (CAPIT)

Peers

Countries citing papers authored by Ray L. Watts

Since Specialization

Citations

This map shows the geographic impact of Ray L. Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray L. Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray L. Watts more than expected).

Fields of papers citing papers by Ray L. Watts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray L. Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray L. Watts. The network helps show where Ray L. Watts may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ray L. Watts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ray L. Watts Line = papers co-authored together Ray L. Watts links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Returning to Growth: One Academic Medical Center’s Successful Five-Step Approach to Change Management Selwyn M. Vickers,Anupam Agarwal,Nisha Patel,Etty Benveniste,Dawn Bulgarella,Mona N. Fouad,Craig Hoesley,Keith Jones,Robert P. Kimberly,David A. Rogers,Jean Ann Larson,Toni R. Leeth,LaKisha Mack,Paige Dorman,Tyler Furgerson,Jane Longshore,Ray L. Watts	2021	3
2	Spatial Topographies of Unilateral Subthalamic Nucleus Deep Brain Stimulation Efficacy for Ipsilateral, Contralateral, Midline, and Total Parkinson Disease Motor Symptoms Mahesh B. Shenai,Andrew Romeo,Harrison C. Walker,Stephanie Guthrie,Ray L. Watts,Barton L. Guthrie	2015	9
3	Reliability of a new scale for essential tremor Rodger J. Elble,Cynthia Comella,Stanley Fahn,Mark Hallett,Joseph Jankovic,Jorge L. Juncos,Peter A. LeWitt,Kelly E. Lyons,William G. Ondo,Rajesh Pahwa,Kapil D. Sethi,Natividad Stover,Daniel Tarsy,Claudia Testa,Ron Tintner,Ray L. Watts,Theresa Zesiewicz	2012	168
4	Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor Harrison C. Walker,He Huang,Christopher L. Gonzalez,James Bryant,Jeffrey F. Killen,Robert C. Knowlton,Erwin B. Montgomery,Gary Cutter,Abidin Yildirim,B.L. Guthrie,Ray L. Watts	2012	32
5	Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson’s disease Amy W. Amara,David G. Standaert,Stephanie Guthrie,Gary Cutter,Ray L. Watts,Harrison C. Walker	2011	52
6	Quality of Life in Parkinson's Disease Patients Following Adjunctive Tolcapone Therapy: Results of an Open-Label, Multicenter, Community-Based Trial Kapil D. Sethi,Stewart A. Factor,Ray L. Watts	2010	5
7	Striatal Overexpression of ΔFosB Reproduces Chronic Levodopa-Induced Involuntary Movements Xuebing Cao,Toru Yasuda,Subramaniam Uthayathas,Ray L. Watts,M. Maral Mouradian,Hideki Mochizuki,Stella M. Papa	2010	74
8	The Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease Timothy J. O’Brien,Virginia G. Wadley,Anthony P. Nicholas,Natividad Stover,Ray L. Watts,H. Randall Griffith	2009	14
9	Weight changes associated with unilateral STN DBS and advanced PD Harrison C. Walker,Michael Lyerly,Gary Cutter,Johnson Hagood,Natividad Stover,Stephanie Guthrie,Barton L. Guthrie,Ray L. Watts	2009	37
10	Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia H. Randall Griffith,Jan A. den Hollander,Ozioma C. Okonkwo,Timothy O’Brien,Ray L. Watts,Daniel Marson	2008	33
11	Medical decision‐making capacity in cognitively impaired Parkinson's disease patients without dementia Roy C. Martin,Ozioma C. Okonkwo,Joni Hill,H. Randall Griffith,Kristen Triebel,Alfred A. Bartolucci,Anthony P. Nicholas,Ray L. Watts,Natividad Stover,Lindy E. Harrell,David Clark,Daniel Marson	2008	54
12	Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa Robert A. Hauser,Olivier Rascol,Amos D. Korczyn,A. Jon Stoessl,Ray L. Watts,Werner Poewe,Peter Paul De Deyn,Anthony E. Lang	2007	186
13	A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease Liling Warren,Rachel A. Gibson,Lianna Ishihara,Ramu Elango,Zhengyu Xue,P. Anthony Akkari,Leigh Ragone,Rajesh Pahwa,Joseph Jankovic,Martha Nance,Alan Freeman,Ray L. Watts,Fayçal Hentati	2007	31
14	Intrastriatal Implantation of Human Retinal Pigment Epithelial Cells Attached to Microcarriers in Advanced Parkinson Disease Natividad Stover,Roy A.E. Bakay,Thyagarajan Subramanian,Cathy D. Raiser,Michael L. Cornfeldt,Alfred W. Schweikert,Richard C. Allen,Ray L. Watts	2005	95
15	Benefits and Risks of Pharmacological Treatments for Essential Tremor Kelly E. Lyons,Rajesh Pahwa,Cynthia Comella,Mahmood Eisa,Rodger J. Elble,Stanley Fahn,Joseph Jankovic,Jorge L. Juncos,William C. Koller,William G. Ondo,Kapil D. Sethi,Matthew B. Stern,Caroline M. Tanner,Ron Tintner,Ray L. Watts	2003	68
16	Corticobasal Degeneration Natividad Stover,Ray L. Watts	2001	37
17	Movement disorders : neurologic principles and practice Ray L. Watts,William C. Koller	1997	206
18	Core assessment program for intracerebral transplantations (CAPIT)breakdown → J. William Langston,Håkan Widner,Christopher G. Goetz,David J. Brooks,S Fahn,Thomas B. Freeman,Ray L. Watts	1992	861
19	Mitochondrial oxidative phosphorylation defects in parkinson's disease John M. Shoffner,Ray L. Watts,Jorge L. Juncos,Antonio Torroni,Douglas C. Wallace	1991	274
20	Effect of adrenal-caudate transplantation on CSF levels of salsolinol sulfate in patients with Parkinson’s disease Bahjat A. Faraj,V M Camp,Ray L. Watts	1990	5

About Ray L. Watts

Ray L. Watts is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 84 papers that have together received 6.0k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (54 papers), Neurological disorders and treatments (40 papers), Transcranial Magnetic Stimulation Studies (12 papers), Genetic Neurodegenerative Diseases (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers), Neurological diseases and metabolism (7 papers), Neuroscience and Neural Engineering (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). The work is most often cited by research in Neurology (4.3k citations), Cellular and Molecular Neuroscience (2.1k citations) and Neurology (747 citations). Ray L. Watts has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jorge L. Juncos, David J. Brooks, Christopher G. Goetz, S Fahn, J. William Langston, Håkan Widner, Thomas B. Freeman, William C. Koller, Natividad Stover and Antonio Torroni.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact